Berlin Research Lab
The Berlin Research Lab is an initiative by Pfizer in Germany, its goal is to foster innovation and promote cooperation between partner companies. For example, research partners can come from biopharmaceutical or biomedical research backgrounds. Germany’s dynamic biotech sector is one of the important initiators for the pharmaceutical research.
A wide array of project cooperation is conceivable. Ranging from, drug development or new diagnostic procedures. To the development or optimisation of therapeutic offerings.
Of particular interest are partnerships in the following areas:
- Inflammatory diseases & Immunology
- Cardiovascular & Metabolic diseases
- Neuroscience & Pain
- Cancer disease
- Rare diseases
Institutions and companies, who are interested in research and development in these fields and a partnership with Pfizer can contact us directly. Please use the contact form. We are looking forward to your suggestions and guarantee fast processing of your inquiry.